Home » ABBOTT, MEDINOL SETTLING PATENT SUIT AGAINST ABBOTT STENT
ABBOTT, MEDINOL SETTLING PATENT SUIT AGAINST ABBOTT STENT
Abbott Laboratories Inc. is finalizing a patent infringement case settlement with Israeli company Medinol Ltd. that could free Abbott's Xience drug-coated stent medical device from an entanglement as Abbott works to bring the product to the U.S. market.
Easy Bourse (http://www.easybourse.com/Website/dynamic/News.php?NewsID=25444&lang=fra&NewsRubrique=2)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May